Skip to main content
OpenTrials

Clinical trial condition

Cutaneous Squamous Cell Carcinoma

Explore clinical trials studying Cutaneous Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

56 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Cutaneous Squamous Cell Carcinoma trial results

Completed

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

NCT03889912

Conditions
Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +5 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • TCR Medical Corporation San Diego, California, United States
  • Dermatology Associates of the Palm Beaches Delray Beach, Florida, United States
  • MetroDerm Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Completed

Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma

NCT04154943

Conditions
Cutaneous Squamous Cell Carcinoma
Locations
  • Regeneron Study Site Palo Alto, California, United States
  • Regeneron Study Site Washington D.C., District of Columbia, United States
  • Regeneron Study Site Miami, Florida, United States
  • Regeneron Study Site Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

CemiplimAb Survivorship Epidemiology

NCT03836105

Conditions
Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +5 more
Locations
  • Oncology Specialties, PC - Clearview Cancer Institute Huntsville, Alabama, United States
  • Dignity Health St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • University of California San Diego La Jolla, California, United States
View all 53 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details
Completed

Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

NCT03524326

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +9 more
Locations
  • Memoral Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States
View Trial Details

Related conditions